PDF herunterladen
Journal of Pediatric Neurology 2024; 22(05): 347-358
DOI: 10.1055/s-0044-1786999
Review Article

Polymicrogyria, Cobblestone Malformations, and Tubulin Mutation (Overmigration beyond Pial Limiting Membrane): Diagnosis, Treatment, and Rehabilitation Approach

Manuela Lo Bianco   *
1   Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
,
Valeria Fichera   *
1   Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
,
Antonio Zanghì   *
2   Department of Medical and Surgical Sciences and Advanced Technologies, Research Center for Surgery of Complex Malformation Syndromes of Transition and Adulthood, University of Catania, Catania, Italy
,
Andrea D. Praticò
3   Chair of Pediatrics, Department of Medicine and Surgery, Kore University, Enna, Italy
,
Raffaele Falsaperla
4   Neonatal Intensive Care Unit and Neonatology, University Hospital “Policlinico Rodolico-San Marco,” Catania, Italy
,
Michele Vecchio
5   Rehabilitation Unit, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy
,
Francesco Marino
6   Department of Medical Surgical Sciences and Advanced Technologies, University Hospital Policlinico “G. Rodolico-San Marco,” Catania, Italy
,
Stefano Palmucci
7   Department of Medical Surgical Sciences and Advanced Technologies, IPTRA Unit, University Hospital Policlinico “G. Rodolico-San Marco,” Catania, Italy
,
Giuseppe Belfiore
8   Department of Medical Surgical Sciences and Advanced Technologies, Unit of Radiology 1, University Hospital Policlinico “G. Rodolico-San Marco,” Catania, Italy
,
Pietro Foti
8   Department of Medical Surgical Sciences and Advanced Technologies, Unit of Radiology 1, University Hospital Policlinico “G. Rodolico-San Marco,” Catania, Italy
,
Agata Polizzi
9   Chair of Pediatrics, Department of Educational Sciences, University of Catania, Catania, Italy
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Polymicrogyria, cobblestone malformations, and tubulinopathies constitute a group of neuronal migration abnormalities beyond the pial limiting membrane. Their etiopathogenesis remains unclear, with proposed environmental and genetic factors, including copy number variations and single-gene disorders, recently categorized.

Polymicrogyria features numerous small circumvolutions separated by large, shallow grooves, often affecting the perisylvian cortex with various presentations. Clinical manifestations vary depending on lesion degree, extent, and location, commonly including epilepsy, encephalopathies, spastic tetraparesis, mental retardation, and cortical function deficits.

Cobblestone malformations exhibit a Roman-like pavement cortex, affecting both hemispheres symmetrically due to disruption of the glia limitans, frequently linked to glycosyltransferase gene mutations. Classified separately from lissencephaly type II, they are associated with congenital muscular dystrophy syndromes such as Fukuyama congenital muscular dystrophy, Walker–Warburg syndrome, and muscle–eye–brain disease.

Tubulinopathies encompass diverse cerebral malformations resulting from α-tubulin isotype gene variants, exhibiting a wide clinical spectrum including motor/cognitive impairment, facial diplegia, strabismus, and epilepsy.

Diagnosis relies on magnetic resonance imaging (MRI) with age-specific protocols, highlighting the gray–white junction as a polymicrogyria marker, though neonatal diagnosis may be challenging due to technical and brain maturity issues.

To date, no effective treatments are available and management include physiotherapy, speech and language therapy, and vision training program for oculomotor disabilities; antiepileptic drugs are commonly necessary, and most severe forms usually require specific nutritional support.

Keywords

polymicrogyria - tubulin - neuronal migration - genetics - rehabilitation

* These authors have contributed equally to the article.




Publikationsverlauf

Eingereicht: 05. Dezember 2023

Angenommen: 04. April 2024

Artikel online veröffentlicht:
29. Mai 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. A developmental and genetic classification for malformations of cortical development. Neurology 2005; 65 (12) 1873-1887
    CrossrefPubMedGoogle Scholar
  • 2 Ruggieri M, Praticò AD, Serra A. et al. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms. Childs Nerv Syst 2017; 33 (04) 549-560
    CrossrefPubMedGoogle Scholar
  • 3 Stutterd CA, Leventer RJ. Polymicrogyria: a common and heterogeneous malformation of cortical development. Am J Med Genet C Semin Med Genet 2014; 166C (02) 227-239
    CrossrefPubMedGoogle Scholar
  • 4 Falsaperla R, D'Angelo G, Praticò AD. et al. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav 2020; 112: 107361
    CrossrefPubMedGoogle Scholar
  • 5 Barkovich AJ, Kjos BO. Schizencephaly: correlation of clinical findings with MR characteristics. AJNR Am J Neuroradiol 1992; 13 (01) 85-94
    PubMedGoogle Scholar
  • 6 Pavone P, Briuglia S, Falsaperla R. et al. Wide spectrum of congenital anomalies including choanal atresia, malformed extremities, and brain and spinal malformations in a girl with a de novo 5.6-Mb deletion of 13q12.11-13q12.13. Am J Med Genet A 2014; 164A (07) 1734-1743
    CrossrefPubMedGoogle Scholar
  • 7 Leventer RJ, Phelan EM, Coleman LT, Kean MJ, Jackson GD, Harvey AS. Clinical and imaging features of cortical malformations in childhood. Neurology 1999; 53 (04) 715-722
    CrossrefPubMedGoogle Scholar
  • 8 Pavone P, Praticò AD, Ruggieri M, Falsaperla R. Hypomelanosis of Ito: a round on the frequency and type of epileptic complications. Neurol Sci 2015; 36 (07) 1173-1180
    CrossrefPubMedGoogle Scholar
  • 9 Barkovich AJ. Imaging of the cobblestone lissencephalies. AJNR Am J Neuroradiol 1996; 17 (04) 615-618
    PubMedGoogle Scholar
  • 10 Pavone P, Praticò AD, Ruggieri M. et al. Acquired peripheral neuropathy: a report on 20 children. Int J Immunopathol Pharmacol 2012; 25 (02) 513-517
    CrossrefPubMedGoogle Scholar
  • 11 Devisme L, Bouchet C, Gonzalès M. et al. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. Brain 2012; 135 (Pt 2): 469-482
    CrossrefPubMedGoogle Scholar
  • 12 Pratico AD, Ruggieri M, Falsaperla R, Pavone P. A probable topiramate-induced limbs paraesthesia and rigid fingers flexion. Curr Drug Saf 2018; 13 (02) 131-136
    CrossrefPubMedGoogle Scholar
  • 13 Clement E, Mercuri E, Godfrey C. et al. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol 2008; 64 (05) 573-582
    CrossrefPubMedGoogle Scholar
  • 14 Pavone P, Nigro F, Falsaperla R. et al. Hemihydranencephaly: living with half brain dysfunction. Ital J Pediatr 2013; 39: 3
    CrossrefPubMedGoogle Scholar
  • 15 Brun BN, Mockler SRH, Laubscher KM. et al. Comparison of brain MRI findings with language and motor function in the dystroglycanopathies. Neurology 2017; 88 (07) 623-629
    CrossrefPubMedGoogle Scholar
  • 16 Pavone P, Praticò AD, Gentile G. et al. A neurocutaneous phenotype with paired hypo- and hyperpigmented macules, microcephaly and stunted growth as prominent features. Eur J Med Genet 2016; 59 (05) 283-289
    CrossrefPubMedGoogle Scholar
  • 17 Romero DM, Bahi-Buisson N, Francis F. Genetics and mechanisms leading to human cortical malformations. Semin Cell Dev Biol 2018; 76: 33-75
    CrossrefPubMedGoogle Scholar
  • 18 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Rediagnosing one of Smith's patients (John McCann) with “neuromas tumours” (1849). Neurol Sci 2017; 38 (03) 493-499
    CrossrefPubMedGoogle Scholar
  • 19 Amrom D, Tanyalçin I, Verhelst H. et al. Polymicrogyria with dysmorphic basal ganglia? Think tubulin!. Clin Genet 2014; 85 (02) 178-183
    CrossrefPubMedGoogle Scholar
  • 20 Ruggieri M, Polizzi A, Marceca GP, Catanzaro S, Praticò AD, Di Rocco C. Introduction to phacomatoses (neurocutaneous disorders) in childhood. Childs Nerv Syst 2020; 36 (10) 2229-2268
    CrossrefPubMedGoogle Scholar
  • 21 Jansen AC, Oostra A, Desprechins B. et al. TUBA1A mutations: from isolated lissencephaly to familial polymicrogyria. Neurology 2011; 76 (11) 988-992
    CrossrefPubMedGoogle Scholar
  • 22 Incorpora G, Pavone P, Castellano-Chiodo D, Praticò AD, Ruggieri M, Pavone L. Gelastic seizures due to hypothalamic hamartoma: rapid resolution after endoscopic tumor disconnection. Neurocase 2013; 19 (05) 458-461
    CrossrefPubMedGoogle Scholar
  • 23 Raybaud C, Widjaja E. Development and dysgenesis of the cerebral cortex: malformations of cortical development. Neuroimaging Clin N Am 2011; 21 (03) 483-543 , vii
    CrossrefPubMedGoogle Scholar
  • 24 Leonardi S, Praticò AD, Lionetti E, Spina M, Vitaliti G, La Rosa M. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children. World J Gastroenterol 2012; 18 (40) 5729-5733
    CrossrefPubMedGoogle Scholar
  • 25 Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 2014; 13 (07) 710-726
    CrossrefPubMedGoogle Scholar
  • 26 Palano GM, Praticò AD, Praticò ER. et al. Accidental ethyl alcohol intoxication in a 30-day-old infant. Clinical findings and neurological follow-up [in Italian]. Minerva Pediatr 2007; 59 (03) 275-279
    PubMedGoogle Scholar
  • 27 Volpe JJ, Inder TE, Darras BT. Volpe's Neurology of the Newborn. 6th ed. Elsevier; 2017. Accessed April 18, 2022 at: https://www.elsevier.com/books/volpes-neurology-of-the-newborn/volpe/978-0-323-42876-7
    PubMedGoogle Scholar
  • 28 Fiumara A, Lanzafame G, Arena A. et al. COVID-19 pandemic outbreak and its psychological impact on patients with rare lysosomal diseases. J Clin Med 2020; 9 (09) 2716
    CrossrefPubMedGoogle Scholar
  • 29 Bahi-Buisson N, Maillard C. Tubulinopathies overview. In: Adam MP, Everman DB, Mirzaa GM. , et al., eds. GeneReviews®. University of Washington, Seattle; 1993. . Accessed August 22, 2022 at: http://www.ncbi.nlm.nih.gov/books/NBK350554/
    Google Scholar
  • 30 Praticò AD, Leonardi S. Immunotherapy for food allergies: a myth or a reality?. Immunotherapy 2015; 7 (02) 147-161
    CrossrefPubMedGoogle Scholar
  • 31 Jansen AC, Robitaille Y, Honavar M. et al. The histopathology of polymicrogyria: a series of 71 brain autopsy studies. Dev Med Child Neurol 2016; 58 (01) 39-48
    CrossrefPubMedGoogle Scholar
  • 32 Salafia S, Praticò AD, Pizzo E, Greco F, Di Bella D. Hemiconvulsion-hemiplegia-epilepsy syndrome. Magnetic resonance findings in a 3-year-old boy. Neurol Neurochir Pol 2013; 47 (06) 584-589
    CrossrefPubMedGoogle Scholar
  • 33 Nissenkorn A, Michelson M, Ben-Zeev B, Lerman-Sagie T. Inborn errors of metabolism: a cause of abnormal brain development. Neurology 2001; 56 (10) 1265-1272
    CrossrefPubMedGoogle Scholar
  • 34 Praticò AD, Ruggieri M. COVID-19 vaccination for children: may be necessary for the full eradication of the disease. Pediatr Res 2021; 90 (06) 1102-1103
    CrossrefPubMedGoogle Scholar
  • 35 Marques Dias MJ, Harmant-van Rijckevorsel G, Landrieu P, Lyon G. Prenatal cytomegalovirus disease and cerebral microgyria: evidence for perfusion failure, not disturbance of histogenesis, as the major cause of fetal cytomegalovirus encephalopathy. Neuropediatrics 1984; 15 (01) 18-24
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 36 Ruggieri M, Polizzi A, Catanzaro S, Bianco ML, Praticò AD, Di Rocco C. Neurocutaneous melanocytosis (melanosis). Childs Nerv Syst 2020; 36 (10) 2571-2596
    CrossrefPubMedGoogle Scholar
  • 37 Aicardi J. Aicardi syndrome. Brain Dev 2005; 27 (03) 164-171
    CrossrefPubMedGoogle Scholar
  • 38 Praticò AD, Mistrello G, La Rosa M. et al. Immunotherapy: a new horizon for egg allergy?. Expert Rev Clin Immunol 2014; 10 (05) 677-686
    CrossrefPubMedGoogle Scholar
  • 39 Volpe JJ, Adams RD. Cerebro-hepato-renal syndrome of Zellweger: an inherited disorder of neuronal migration. Acta Neuropathol 1972; 20 (03) 175-198
    CrossrefPubMedGoogle Scholar
  • 40 Praticò AD. COVID-19 pandemic for pediatric health care: disadvantages and opportunities. Pediatr Res 2021; 89 (04) 709-710
    CrossrefPubMedGoogle Scholar
  • 41 Takashima S, Chan F, Becker LE, Houdou S, Suzuki Y. Cortical cytoarchitectural and immunohistochemical studies on Zellweger syndrome. Brain Dev 1991; 13 (03) 158-162
    CrossrefPubMedGoogle Scholar
  • 42 Praticò AD, Giallongo A, Arrabito M. et al. SCN2A and its related epileptic phenotypes. J Pediatr Neurol 2023; 21 (03) 173-185
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 43 Inder TE, Huppi PS, Zientara GP. et al. The postmigrational development of polymicrogyria documented by magnetic resonance imaging from 31 weeks' postconceptional age. Ann Neurol 1999; 45 (06) 798-801
    CrossrefPubMedGoogle Scholar
  • 44 Praticò AD, Falsaperla R, Comella M, Belfiore G, Polizzi A, Ruggieri M. Case report: a gain-of-function of hamartin may lead to a distinct “inverse TSC1-hamartin” phenotype characterized by reduced cell growth. Front Pediatr 2023; 11: 1101026
    CrossrefPubMedGoogle Scholar
  • 45 Bankl H, Jellinger K. Central nervous system injuries following fetal carbon monoxide poisoning [in German]. Beitr Pathol Anat 1967; 135 (03) 350-376
    PubMedGoogle Scholar
  • 46 Trifiletti RR, Incorpora G, Polizzi A, Cocuzza MD, Bolan EA, Parano E. Aicardi syndrome with multiple tumors: a case report with literature review. Brain Dev 1995; 17 (04) 283-285
    CrossrefPubMedGoogle Scholar
  • 47 Golden JA, Harding BN. Cortical malformations: unfolding polymicrogyria. Nat Rev Neurol 2010; 6 (09) 471-472
    CrossrefPubMedGoogle Scholar
  • 48 Polizzi A, Pavone P, Parano E, Incorpora G, Ruggieri M. Lack of progression of brain atrophy in Aicardi-Goutières syndrome. Pediatr Neurol 2001; 24 (04) 300-302
    CrossrefPubMedGoogle Scholar
  • 49 Judkins AR, Martinez D, Ferreira P, Dobyns WB, Golden JA. Polymicrogyria includes fusion of the molecular layer and decreased neuronal populations but normal cortical laminar organization. J Neuropathol Exp Neurol 2011; 70 (06) 438-443
    CrossrefPubMedGoogle Scholar
  • 50 Leuzzi V, Mastrangelo M, Polizzi A. et al. Report of two never treated adult sisters with aromatic L-amino acid decarboxylase deficiency: a portrait of the natural history of the disease or an expanding phenotype?. JIMD Rep 2015; 15: 39-45
    PubMedGoogle Scholar
  • 51 Barth PG. Disorders of neuronal migration. Can J Neurol Sci 1987; 14 (01) 1-16
    CrossrefPubMedGoogle Scholar
  • 52 Ruggieri M, Polizzi A. From Aldrovandi's “Homuncio” (1592) to Buffon's girl (1749) and the “Wart Man” of Tilesius (1793): antique illustrations of mosaicism in neurofibromatosis?. J Med Genet 2003; 40 (03) 227-232
    CrossrefPubMedGoogle Scholar
  • 53 Parrini E, Conti V, Dobyns WB, Guerrini R. Genetic basis of brain malformations. Mol Syndromol 2016; 7 (04) 220-233
    CrossrefPubMedGoogle Scholar
  • 54 Ruggieri M, Iannetti P, Pavone L. Delineation of a newly recognized neurocutaneous malformation syndrome with “cutis tricolor”. Am J Med Genet A 2003; 120A (01) 110-116
    CrossrefPubMedGoogle Scholar
  • 55 Moser HW. The peroxisome: nervous system role of a previously underrated organelle. The 1987 Robert Wartenberg lecture. Neurology 1988; 38 (10) 1617-1627
    CrossrefPubMedGoogle Scholar
  • 56 Ruggieri M, Milone P, Pavone P. et al. Nevus vascularis mixtus (cutaneous vascular twin nevi) associated with intracranial vascular malformation of the Dyke-Davidoff-Masson type in two patients. Am J Med Genet A 2012; 158A (11) 2870-2880
    CrossrefPubMedGoogle Scholar
  • 57 Guerrini R, Filippi T. Neuronal migration disorders, genetics, and epileptogenesis. J Child Neurol 2005; 20 (04) 287-299
    CrossrefPubMedGoogle Scholar
  • 58 Ruggieri M, Iannetti P, Clementi M. et al. Neurofibromatosis type 1 and infantile spasms. Childs Nerv Syst 2009; 25 (02) 211-216
    CrossrefPubMedGoogle Scholar
  • 59 Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J, Martinez V, Palencia R. Unilateral polymicrogyria: a common cause of hemiplegia of prenatal origin. Brain Dev 2001; 23 (04) 216-222
    CrossrefPubMedGoogle Scholar
  • 60 Pavone P, Praticò AD, Pavone V. et al. Ataxia in children: early recognition and clinical evaluation. Ital J Pediatr 2017; 43 (01) 6
    CrossrefPubMedGoogle Scholar
  • 61 Dixon-Salazar T, Silhavy JL, Marsh SE. et al. Mutations in the AHI1 gene, encoding jouberin, cause Joubert syndrome with cortical polymicrogyria. Am J Hum Genet 2004; 75 (06) 979-987
    CrossrefPubMedGoogle Scholar
  • 62 Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 2001; 101 (02) 178-180
    CrossrefPubMedGoogle Scholar
  • 63 Wieck G, Leventer RJ, Squier WM. et al. Periventricular nodular heterotopia with overlying polymicrogyria. Brain 2005; 128 (Pt 12): 2811-2821
    CrossrefPubMedGoogle Scholar
  • 64 Ruggieri M, McShane MA. Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child 1998; 79 (05) 423-426
    CrossrefPubMedGoogle Scholar
  • 65 Jamuar SS, Lam ATN, Kircher M. et al. Somatic mutations in cerebral cortical malformations. N Engl J Med 2014; 371 (08) 733-743
    CrossrefPubMedGoogle Scholar
  • 66 Ruggieri M, Huson SM. The neurofibromatoses. An overview. Ital J Neurol Sci 1999; 20 (02) 89-108
    CrossrefPubMedGoogle Scholar
  • 67 Guerreiro MM, Andermann E, Guerrini R. et al. Familial perisylvian polymicrogyria: a new familial syndrome of cortical maldevelopment. Ann Neurol 2000; 48 (01) 39-48
    CrossrefPubMedGoogle Scholar
  • 68 Pratico AD, Longo L, Mansueto S. et al. Off-label use of drugs and adverse drug reactions in pediatric units: a prospective, multicenter study. Curr Drug Saf 2018; 13 (03) 200-207
    CrossrefPubMedGoogle Scholar
  • 69 Chang BS, Piao X, Bodell A. et al. Bilateral frontoparietal polymicrogyria: clinical and radiological features in 10 families with linkage to chromosome 16. Ann Neurol 2003; 53 (05) 596-606
    CrossrefPubMedGoogle Scholar
  • 70 Ruggieri M. Cutis tricolor: congenital hyper- and hypopigmented lesions in a background of normal skin with and without associated systemic features: further expansion of the phenotype. Eur J Pediatr 2000; 159 (10) 745-749
    CrossrefPubMedGoogle Scholar
  • 71 Piao X, Basel-Vanagaite L, Straussberg R. et al. An autosomal recessive form of bilateral frontoparietal polymicrogyria maps to chromosome 16q12.2-21. Am J Hum Genet 2002; 70 (04) 1028-1033
    CrossrefPubMedGoogle Scholar
  • 72 Ruggieri M, Polizzi A, Pavone L, Musumeci S. Thalamic syndrome in children with measles infection and selective, reversible thalamic involvement. Pediatrics 1998; 101 (1 Pt 1): 112-119
    CrossrefPubMedGoogle Scholar
  • 73 Chang BS, Piao X, Giannini C. et al. Bilateral generalized polymicrogyria (BGP): a distinct syndrome of cortical malformation. Neurology 2004; 62 (10) 1722-1728
    CrossrefPubMedGoogle Scholar
  • 74 Baulac S, Lenk GM, Dufresnois B. et al. Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria. Neurology 2014; 82 (12) 1068-1075
    CrossrefPubMedGoogle Scholar
  • 75 Mirzaa GM, Rivière JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 2013; 163C (02) 122-130
    CrossrefPubMedGoogle Scholar
  • 76 Robin NH, Taylor CJ, McDonald-McGinn DM. et al. Polymicrogyria and deletion 22q11.2 syndrome: window to the etiology of a common cortical malformation. Am J Med Genet A 2006; 140 (22) 2416-2425
    CrossrefPubMedGoogle Scholar
  • 77 Bahi-Buisson N, Poirier K, Boddaert N. et al. Refinement of cortical dysgeneses spectrum associated with TUBA1A mutations. J Med Genet 2008; 45 (10) 647-653
    CrossrefPubMedGoogle Scholar
  • 78 Barkovich AJ. MRI analysis of sulcation morphology in polymicrogyria. Epilepsia 2010; 51 (0 1, Suppl 1): 17-22
    CrossrefPubMedGoogle Scholar
  • 79 Leventer RJ, Jansen A, Pilz DT. et al. Clinical and imaging heterogeneity of polymicrogyria: a study of 328 patients. Brain 2010; 133 (Pt 5): 1415-1427
    CrossrefPubMedGoogle Scholar
  • 80 Barkovich AJ. Current concepts of polymicrogyria. Neuroradiology 2010; 52 (06) 479-487
    CrossrefPubMedGoogle Scholar
  • 81 Takanashi J, Barkovich AJ. The changing MR imaging appearance of polymicrogyria: a consequence of myelination. AJNR Am J Neuroradiol 2003; 24 (05) 788-793
    PubMedGoogle Scholar
  • 82 De Ciantis A, Barkovich AJ, Cosottini M. et al. Ultra-high-field MR imaging in polymicrogyria and epilepsy. AJNR Am J Neuroradiol 2015; 36 (02) 309-316
    CrossrefPubMedGoogle Scholar
  • 83 Stutterd CA, Dobyns WB, Jansen A. et al. Polymicrogyria overview. In: GeneReviews® [Internet]. Seattle, WA:: University of Washington, Seattle;; 1993
    Google Scholar
  • 84 Chiaramonte R, Pavone P, Vecchio M. Speech rehabilitation in dysarthria after stroke: a systematic review of the studies. Eur J Phys Rehabil Med 2020; 56 (05) 547-562
    CrossrefPubMedGoogle Scholar
  • 85 Chiaramonte R, Vecchio M. Dysarthria and stroke. The effectiveness of speech rehabilitation. A systematic review and meta-analysis of the studies. Eur J Phys Rehabil Med 2021; 57 (01) 24-43
    CrossrefPubMedGoogle Scholar
  • 86 Chiaramonte R, Vecchio M. A systematic review of measures of dysarthria severity in stroke patients. PM R 2021; 13 (03) 314-324
    CrossrefPubMedGoogle Scholar
  • 87 Vecchio M, Gracies JM, Panza F. et al. Change in coefficient of fatigability following rapid, repetitive movement training in post-stroke spastic paresis: a prospective open-label observational study. J Stroke Cerebrovasc Dis 2017; 26 (11) 2536-2540
    CrossrefPubMedGoogle Scholar
  • 88 Cossu M, Pelliccia V, Gozzo F. et al. Surgical treatment of polymicrogyria-related epilepsy. Epilepsia 2016; 57 (12) 2001-2010
    CrossrefPubMedGoogle Scholar
  • 89 Maillard LG, Tassi L, Bartolomei F. et al. Stereoelectroencephalography and surgical outcome in polymicrogyria-related epilepsy: a multicentric study. Ann Neurol 2017; 82 (05) 781-794
    CrossrefPubMedGoogle Scholar
  • 90 Marciniak C, McAllister P, Walker H. et al; International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group. Efficacy and safety of abobotulinumtoxinA (Dysport) for the treatment of hemiparesis in adults with upper limb spasticity previously treated with botulinum toxin: subanalysis from a phase 3 randomized controlled trial. PM R 2017; 9 (12) 1181-1190
    CrossrefPubMedGoogle Scholar
  • 91 Gracies JM, Jech R, Valkovic P. et al. When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?. Brain Commun 2020; 3 (01) fcaa201
    CrossrefPubMedGoogle Scholar
  • 92 Floresta G, Patamia V, Gentile D. et al. Repurposing of FDA-approved drugs for treating iatrogenic botulism: a paired 3D-QSAR/docking approach† . ChemMedChem 2020; 15 (02) 256-262
    CrossrefPubMedGoogle Scholar
  • 93 Gentile D, Floresta G, Patamia V. et al. An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin A inhibitors. Int J Mol Sci 2020; 21 (24) 9470
    CrossrefPubMedGoogle Scholar